|
LPAR2 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.42640035736019E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.70010000206156E-08 |
| Normal-vs-Stage2 |
6.838700E-04 |
| Normal-vs-Stage3 |
3.64259999940941E-08 |
| Normal-vs-Stage4 |
4.04154487654296E-12 |
| Stage1-vs-Stage2 |
7.268000E-01 |
| Stage1-vs-Stage3 |
2.242600E-01 |
| Stage1-vs-Stage4 |
4.997100E-04 |
| Stage2-vs-Stage3 |
6.503000E-01 |
| Stage2-vs-Stage4 |
2.696100E-02 |
| Stage3-vs-Stage4 |
2.048000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.23469995233694E-09 |
| Normal-vs-AfricanAmerican |
1.35180000526702E-08 |
| Normal-vs-Asian |
2.304100E-03 |
| Caucasian-vs-AfricanAmerican |
6.271500E-02 |
| Caucasian-vs-Asian |
5.727800E-02 |
| AfricanAmerican-vs-Asian |
1.622580E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.606270E-04 |
| Normal-vs-Female |
3.01959568460575E-11 |
| Male-vs-Female |
2.918200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.11360000001992E-06 |
| Normal-vs-Age(41-60Yrs) |
4.14539513826639E-11 |
| Normal-vs-Age(61-80Yrs) |
4.24530000042722E-07 |
| Normal-vs-Age(81-100Yrs) |
3.048600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.996180E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.965030E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.614000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.154400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.802400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.779600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.99699999554093E-08 |
| Classical-VS-Follicular |
5.542600E-01 |
| Classical-VS-Other |
3.689200E-01 |
| Classical-VS-Normal |
1.75519999645601E-08 |
| Tall-VS-Follicular |
7.186500E-04 |
| Tall-VS-Other |
9.676500E-02 |
| Tall-VS-Normal |
4.44089209850063E-16 |
| Follicular-VS-Other |
3.195000E-01 |
| Follicular-VS-Normal |
1.54100000004931E-06 |
| Other-VS-Normal |
9.051200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.64060000002109E-06 |
| Normal-vs-N1 |
1.0761003199633E-10 |
| N0-vs-N1 |
1.302750E-03 |
|
|
